News
One study found a modest risk of developing non-arteritic anterior ischaemic optic neuropathy (NAOIN), a rare eye condition ...
New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an ...
This phase 2b/3 trial follows new, positive 2-year data from the phase 2 ALTITUDE trial, in which sura-vec was well-tolerated ...
The agreement is for a planned clinical trial of AXPAXLI (also known as OTX-TKI) for the treatment of non-proliferative ...
2h
Irish Star on MSNWeight-loss drugs linked to devastating eye condition, new research confirms
Research carried out over the past year has shown a link between using GLP-1 medication for weight loss and a dangerous eye condition that results in sudden vision loss ...
For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a ...
MUSCAT: The National Programme for Early Detection of Diabetic Retinopathy using artificial intelligence (AI) technologies ...
1d
MedPage Today on MSNPopular Diabetes Drugs Linked to Small Risk of Retinal, Optic Nerve Disorders
The risk of new-onset diabetic retinopathy (DR) increased slightly, but significantly, in patients taking GLP-1 receptor ...
A new study published in Nutrition and Health has found that Vitamin D deficiency is independently associated with a range of ...
An observational study of 160,000 patients with diabetes taking GLP-1 drugs finds no heightened risk for retinopathy ...
Diabetic retinopathy, a type of diabetic eye disease, is one of the leading causes of blindness in the United States. Despite this, almost 40% of people with diabetes don’t get an annual eye exam.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results